Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at the University of Oxford and their collaborators have demonstrated that simple, rapid, and inexpensive tests can detect deadly contaminants in medicinal syrups - contaminants that have tragically led to the deaths of hundreds of children worldwide.

Medicinal Syrups © Getty Images (areeya_ann)

In 2022, contaminated medicinal syrups caused the deaths of more than 300 children across Indonesia, The Gambia, Uzbekistan and Cameroon. Only two months ago, at least a further 24 deaths were reported in India. In response, Oxford’s DEG-EG team is developing novel tests to identify these lethal contaminants in both medicinal syrups and their raw materials.

The team has successfully repurposed commercially available rapid tests, each costing less than £1:

  • Alcohol test strips, commonly used to check saliva or breast milk for traces of alcohol before driving or infant feeding, were shown to detect contaminants in medicinal syrups and raw materials in under two minutes.
  • Disposable breathalysers, also used for alcohol detection, identified contaminants in raw materials in as little as ten seconds.

These methods offer simple, fast and low-cost tools for identifying contamination of syrups in pharmaceutical supply chains - a crucial step toward preventing future tragedies.

 

Read the full story on the University of Oxford website.

 

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience